---
figid: PMC6327844__nihms-1003323-f0002
figlink: /pmc/articles/PMC6327844/figure/F2/
number: F2
caption: 'Classes of drugs that modulate the cGMP-PKG pathway in relation to SERCA2a
  within cardiac myocytes (cardiomyocytes). cGMP is produced by sGC, which is activated
  by NO, or by the transmembrane pGC, which is activated by natriuretic peptides (ANP,
  BNP). Class of NO and nitroxyl donors is shown (①). sGC stimulators (②) target only
  nonoxidized sGC (Fe2+); in contrast, sGC activators (③) target oxidized sGC (Fe3+)
  by ROS. NEPs responsible for ANP and BNP breakdown are indicated (④). PDE5 operates
  the breakdown of cGMP produced by sGC, while PDE9 is responsible for the breakdown
  of cGMP produced by pGC (⑤). Abbreviations: 5’GMP, guanosine 5’-monophosphate; Ang-II,
  angiotensin-Π; ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide;
  cGMP, cyclic guanosine monophosphate; ECM, extracellular matrix; ET-1, endothelin-1;
  GTP, guanosine triphosphate; HFpEF, heart failure with preserved ejection fraction;
  IC, intracellular; LTCC, L-type calcium channel; NEP, inhibitor of neprilysin; NO,
  nitric oxide; P, phosphate group; PDE5, phosphodiesterase 5; pGC, particulate guanylate
  cyclase; PKG, protein kinase G; PLB, phospholamban; ROS, reactive oxygen species;
  RyR2, ryanodine receptor 2; SERCA2a, sarco-/endoplasmic reticulum calcium ATPase
  2a; sGC, soluble guanylate cyclase; SR, sarco-/endoplasmic reticulum; T-tubule,
  transverse tubule; TGF-β, transforming growth factor-β. Figure adapted with permission
  from Kovacs et al. (12; https://creativecommons.Org/licenses/by/4.0/).'
pmcid: PMC6327844
papertitle: 'Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic
  Approach and Review of Contemporary Clinical Trials.'
reftext: Ravi B. Patel, et al. Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:41-63.
pmc_ranked_result_index: '223049'
pathway_score: 0.9262289
filename: nihms-1003323-f0002.jpg
figtitle: Classes of drugs that modulate the cGMP-PKG pathway in relation to SERCA2a
  within cardiac myocytes (cardiomyocytes)
year: '2019'
organisms: Homo sapiens
ndex: 513eab7e-df0a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6327844__nihms-1003323-f0002.html
  '@type': Dataset
  description: 'Classes of drugs that modulate the cGMP-PKG pathway in relation to
    SERCA2a within cardiac myocytes (cardiomyocytes). cGMP is produced by sGC, which
    is activated by NO, or by the transmembrane pGC, which is activated by natriuretic
    peptides (ANP, BNP). Class of NO and nitroxyl donors is shown (①). sGC stimulators
    (②) target only nonoxidized sGC (Fe2+); in contrast, sGC activators (③) target
    oxidized sGC (Fe3+) by ROS. NEPs responsible for ANP and BNP breakdown are indicated
    (④). PDE5 operates the breakdown of cGMP produced by sGC, while PDE9 is responsible
    for the breakdown of cGMP produced by pGC (⑤). Abbreviations: 5’GMP, guanosine
    5’-monophosphate; Ang-II, angiotensin-Π; ANP, atrial natriuretic peptide; BNP,
    brain natriuretic peptide; cGMP, cyclic guanosine monophosphate; ECM, extracellular
    matrix; ET-1, endothelin-1; GTP, guanosine triphosphate; HFpEF, heart failure
    with preserved ejection fraction; IC, intracellular; LTCC, L-type calcium channel;
    NEP, inhibitor of neprilysin; NO, nitric oxide; P, phosphate group; PDE5, phosphodiesterase
    5; pGC, particulate guanylate cyclase; PKG, protein kinase G; PLB, phospholamban;
    ROS, reactive oxygen species; RyR2, ryanodine receptor 2; SERCA2a, sarco-/endoplasmic
    reticulum calcium ATPase 2a; sGC, soluble guanylate cyclase; SR, sarco-/endoplasmic
    reticulum; T-tubule, transverse tubule; TGF-β, transforming growth factor-β. Figure
    adapted with permission from Kovacs et al. (12; https://creativecommons.Org/licenses/by/4.0/).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDE6A
  - PDE4D
  - PDE4A
  - PDE6C
  - PDE8B
  - NPPA
  - PDE4B
  - PDE6B
  - PDE11A
  - PDE1A
  - MME
  - PDE7B
  - PDE3A
  - PDE3B
  - SGCB
  - TGFB2
  - PDE4C
  - PDE10A
  - PDE9A
  - PDE1B
  - PDE1C
  - PDE2A
  - PDE7A
  - PDE8A
  - TGFB1
  - PLB1
  - RYR2
  - TGFB3
  - EDN1
  - PRKG1
  - CGMP
  - Ca2+
  - 5'GMP
  - Microvascular dysfunction
  - Fibrosis
  - Hypertrophy
genes:
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: ANP
  symbol: ANP
  source: hgnc_prev_symbol
  hgnc_symbol: NPPA
  entrez: '4878'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: NEP
  symbol: NEP
  source: hgnc_alias_symbol
  hgnc_symbol: MME
  entrez: '4311'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: SGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PLB
  symbol: PLB
  source: hgnc_alias_symbol
  hgnc_symbol: PLB1
  entrez: '151056'
- word: RYR2
  symbol: RYR2
  source: hgnc_symbol
  hgnc_symbol: RYR2
  entrez: '6262'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-B,ET-1,Ang-II
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
chemicals:
- word: CGMP
  source: MESH
  identifier: C016276
- word: Ca2+
  source: MESH
  identifier: D002118
- word: 5'GMP
  source: MESH
  identifier: D006157
diseases:
- word: Microvascular dysfunction
  source: MESH
  identifier: D017566
- word: Fibrosis
  source: MESH
  identifier: D005355
- word: Hypertrophy
  source: MESH
  identifier: D006984
figid_alias: PMC6327844__F2
redirect_from: /figures/PMC6327844__F2
figtype: Figure
---
